LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

Home・Elenco Azioni・NeoGenomics Inc

NeoGenomics Inc

Chiusa

9.23 1.54

Acquista Vendi

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

9.19

Massimo

9.25

Metriche Chiave
By Trading Economics
Entrata	-7.2M -17M
Vendite	-3.5M 187M
EPS	0.01
Margine di Profitto	-9.164
Dipendenti	2,500
EBITDA	-5.8M -567K

Raccomandazioni
By TipRanks
Raccomandazioni	Acquista
Previsioni per 12 mesi	+61.76% upside

Dividendi
By Dow Jones
Utili prossimi	28 lug 2026

Statistiche di mercato
By TradingEconomics
Capitalizzazione di Mercato	-31M 1.1B
Apertura precedente	7.69
Chiusura precedente	9.23

NeoGenomics Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

22 mag 2026, 18:09 UTC

Discorsi di Mercato

Centralized Crypto Lending Slows in 1Q -- Market Talk

22 mag 2026, 16:54 UTC

Discorsi di Mercato

Crypto Spot Volumes Fall 14% in April -- Market Talk

22 mag 2026, 14:53 UTC

Discorsi di Mercato

USDT Build on Binance May Signal Refreshed Crypto Appetite -- Market Talk

22 mag 2026, 11:51 UTC

Discorsi di Mercato

Bitcoin Dented by U.S. Rate-Rise Bets, Iran War Uncertainty -- Market Talk

22 mag 2026, 07:28 UTC

Discorsi di Mercato

Bitcoin Falls as Investors Weigh Conflicting Iran War Headlines -- Market Talk

21 mag 2026, 17:04 UTC

Discorsi di Mercato

SpaceX Revealed as Top 10 Bitcoin Holder -- Market Talk

21 mag 2026, 16:20 UTC

Discorsi di Mercato

Financial Services Roundup: Market Talk

21 mag 2026, 16:08 UTC

Discorsi di Mercato

Global Forex and Fixed Income Roundup: Market Talk

21 mag 2026, 16:08 UTC

Discorsi di Mercato

Zcash Backtracks After Yesterday's Surge -- Market Talk

21 mag 2026, 15:39 UTC

Discorsi di Mercato

Global Equities Roundup: Market Talk

21 mag 2026, 15:39 UTC

Discorsi di Mercato

Hyperliquid ETFs Gaining Momentum as Price Soars -- Market Talk

21 mag 2026, 13:52 UTC

Discorsi di Mercato

Bitcoin Shows Signs of Repeating 2022 Trading Pattern -- Market Talk

21 mag 2026, 07:03 UTC

Discorsi di Mercato

Bitcoin Falls on Iran War Uncertainty, U.S. Rate Rise Bets -- Market Talk

20 mag 2026, 17:08 UTC

Discorsi di Mercato

Zcash Benefiting From Investments in 'Production-Grade Privacy' -- Market Talk

20 mag 2026, 16:20 UTC

Discorsi di Mercato

Tech, Media & Telecom Roundup: Market Talk

20 mag 2026, 15:51 UTC

Discorsi di Mercato

Global Forex and Fixed Income Roundup: Market Talk

20 mag 2026, 15:51 UTC

Discorsi di Mercato

Zcash Tears Higher in Mostly Positive Day for Crypto -- Market Talk

20 mag 2026, 15:39 UTC

Discorsi di Mercato

Bitcoin Support Seen as $76k, Says Bitfinex -- Market Talk

20 mag 2026, 13:08 UTC

Discorsi di Mercato

Bitcoin Rangebound as ETF Outflows Continue -- Market Talk

20 mag 2026, 12:44 UTC

Discorsi di Mercato

Bitcoin Gains Slightly as U.S. Stock Futures Rise -- Market Talk

20 mag 2026, 07:25 UTC

Discorsi di Mercato

Bitcoin Edges Higher But Iran War Uncertainty Limits Gains -- Market Talk

19 mag 2026, 16:20 UTC

Discorsi di Mercato

Financial Services Roundup: Market Talk

19 mag 2026, 15:54 UTC

Discorsi di Mercato

Global Forex and Fixed Income Roundup: Market Talk

19 mag 2026, 15:54 UTC

Discorsi di Mercato

Bitcoin Holders Under Little Pressure to Sell Despite ETF Outflow -- Market Talk

19 mag 2026, 14:51 UTC

Discorsi di Mercato

Global Forex and Fixed Income Roundup: Market Talk

19 mag 2026, 14:51 UTC

Discorsi di Mercato

Ethereum Down From Near-Term High -- Market Talk

19 mag 2026, 08:26 UTC

Discorsi di Mercato

Bitcoin Edges Higher as Oil Price, Bond Yields Fall -- Market Talk

19 mag 2026, 08:26 UTC

Discorsi di Mercato

Market Talk Roundup: Latest on U.S. Politics

18 mag 2026, 20:50 UTC

Discorsi di Mercato

Basic Materials Roundup: Market Talk

18 mag 2026, 17:22 UTC

Discorsi di Mercato

Tokenized Assets Expected to be Over $1T By 2030 -- Market Talk

Confronto tra pari

Modifica del prezzo

NeoGenomics Inc Previsione

Obiettivo di Prezzo

By TipRanks

61.76% in crescita

Previsioni per 12 mesi

Media 14.93 USD 61.76%

Alto 25 USD

Basso 11 USD

Basato su 10 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per NeoGenomics Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

10 ratings

Acquista

Mantieni

Vendi

Basato sugli analisti di 10 che hanno fornito valutazioni azionarie a NeoGenomics Inc - Dist negli ultimi 3 mesi.

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

Chi Siamo NeoGenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.